1 paper
Qie He, Junfeng Zhu, David Dingli +2
Over the past decade, several targeted therapies (e.g. imatinib, dasatinib, nilotinib) have been developed to treat Chronic Myeloid Leukemia (CML). Despite an initial response to t…